Kolexia
Le Mauff Brigitte
Médecine générale
Hôpital Georges-Clemenceau
Caen, France
73 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Anaphylaxie Hypersensibilité Hypersensibilité médicamenteuse Choc Vascularite Lupus érythémateux disséminé Hypersensibilité immédiate Fasciite Dermatomyosite

Industries

Thermo Fisher Scientific
1 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2022
Novartis
1 collaboration(s)
Dernière en 2022
Alexion
1 collaboration(s)
Dernière en 2021

Dernières activités

Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation.
Journal of inflammation (London, England)   14 février 2024
Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients.
Frontiers in immunology   08 janvier 2024
Interleukin 10 (IL10) and IL15 Significantly Decreased in Chronic Myeloid Leukemia Patients Presenting with Tyrosine Kinase Inhibitor (TKI) Withdrawal Syndrome (TWS). Results from the Prospective, Explorative and Multicenter « Kiwis » Study Designed for TWS. Clinicaltrial.Gov ID: NCT03996096; Study Number: 18-206
65th ASH Annual Meeting Abstracts   02 novembre 2023
Basophil activation test: Feedback and lessons from routine practice in French clinical laboratories.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology   27 juin 2023
Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab.
BMC cancer   09 janvier 2023
Anaphylaxis in France: From health policies to clinical practice. A position statement from the French Allergy Society
Revue francaise d'allergologie (2009)   01 août 2022
The diagnostic challenge of patients with anti-U1-RNP antibodies.
Rheumatology international   27 juillet 2022
Roles of the tissue-type plasminogen activator in immune response.
Cellular immunology   06 novembre 2021
The detection of antithyroid antibodies in cerebrospinal fluid using fluorescent enzyme immuno assay (FEIA) is suitable for biological diagnosis of Hashimoto's encephalopathy.
Annales de biologie clinique   25 octobre 2021
Hypersensibilité au liquide amniotique bovin, apport des tests biologiques
16ème Congrès Francophone d’Allergologie   01 mai 2021